Immunity to melanoma antigens: from self-tolerance to immunotherapy
/in International Publications, Malignant Melanoma /von 2006-01-01 / Adv. Immunol. 2006;90:243-95From pathogen to medicine: HIV-1-derived lentiviral vectors as vehicles for dendritic cell based cancer immunotherapy
/in HIV/AIDS, International Publications /von 2006-01-01 / J Gene Med 2006 Jan;8(1):3-17Understanding and exploiting dendritic cells in human immunodeficiency virus infection using the nonhuman primate model
/in HIV/AIDS, International Publications /von 2006-01-01 / Immunol. Res. 2006;36(1-3):265-74Comparative analysis of DC fused with tumor cells or transfected with tumor total RNA as potential cancer vaccines against hepatocellular carcinoma
/in Hepatocellular Carcinoma, International Publications /von 2006-01-01 / Cytotherapy 2006;8(6):580-8Mahaley Clinical Research Award: chemosensitization of glioma through dendritic cell vaccination
/in Glioblastoma, International Publications /von 2006-01-01 / Clin Neurosurg 2006;53:345-51Generation of DC-based vaccine for therapy of B-CLL patients. Comparison of two methods for enriching monocytic precursors
/in Chronic Leukemia, Dendritic Cells, International Publications /von 2006-01-01 / Cytotherapy 2006;8(4):318-26Genetically modified dendritic cells for therapeutic immunity
/in Dendritic Cells, International Publications /von 2006-01-01 / Tohoku J. Exp. Med. 2006 Jan;208(1):1-8Dendritic cells pulsed with hepatitis C virus NS3 protein induce immune responses and protection from infection with recombinant vaccinia virus expressing NS3
/in Chronic Virus Hepatitis, International Publications /von 2006-01-01 / J. Gen. Virol. 2006 Jan;87(Pt 1):1-10Intrahepatic cholangiocarcinoma with lymph node metastasis successfully treated by immunotherapy with CD3-activated T cells and dendritic cells after surgery: report of a case
/in Gallbladder Cancer, International Publications /von 2006-01-01 / Surg. Today 2006;36(6):559-62
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de